Skip to content

Combined Functional Electrical Stimulation & Robotic Gait Training for Children With Cerebral Palsy

Combined Functional Electrical Stimulation & Robotic Gait Training for Children With Cerebral Palsy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01657994
Enrollment
6
Registered
2012-08-06
Start date
2012-05-31
Completion date
2013-09-30
Last updated
2016-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy

Keywords

cerebral palsy, gait training, robotic, functional electrical stimulation

Brief summary

The purpose of this research study is to learn more about the usefulness of a physical therapy treatment that combines robot-assisted walking with electrical impulses that help to make muscles contract. This treatment is intended for children with cerebral palsy. Up to eleven children with cerebral palsy will receive up to 18 treatments and will have several evaluations before and after treatment.

Interventions

OTHERCombined functional electrical stimulation and robotic gait training

up to 18 sessions of approximately 45 minutes occurring over up to 9 weeks

Sponsors

Cerebral Palsy International Research Foundation
CollaboratorOTHER
Children's Hospital Medical Center, Cincinnati
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
5 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* GMFCS II, III, or IV cerebral palsy * 5-12 years of age * meet safety criteria for robotic gait training (\<300 lbs, intact skin, femoral length 21-47 cm, ability to follow simple instructions) * meet safety criteria for functional electrical stimulation (voluntary hip and knee muscle contraction, intact skin)

Exclusion criteria

* planned major intervention during study period * contractures that interfere with upright stance * history of non-traumatic long bone fracture or clinically significant osteoporosis * significant concurrent illness * significant condition not typically associated with cerebral palsy

Design outcomes

Primary

MeasureTime frame
Change in Gross Motor Function Measure-66 using multiple baseline assessments4 times (9-0 weeks) before treatment, 3 times (6-12 weeks) after treatment

Secondary

MeasureTime frame
Change in Observational Gait Scale4 times (9-0 weeks) before treatment, 3 times (6-12 weeks) after treatment
Change in Modified Ashworth Scale4 times (9-0 weeks) before treatment, 3 times (6-12 weeks) after treatment
Change in Goniometry at the knee4 times (9-0 weeks) before treatment, 3 times (6-12 weeks) after treatment
Change in 6 minute walk4 times (9-0 weeks) before treatment, 3 times (6-12 weeks) after treatment
Change in strength via myometry4 times (9-0 weeks) before treatment, 3 times (6-12 weeks) after treatment
Change in Children's Assessment of Participation and Enjoyment4 times (9-0 weeks) before treatment, 3 times (6-12 weeks) after treatment
Change in Cerebral Palsy Quality of Life Questionnaire4 times (9-0 weeks) before treatment, 3 times (6-12 weeks) after treatment
Change in Canadian Occupational Performance Measure4 times (9-0 weeks) before treatment, 3 times (6-12 weeks) after treatment
Change in 10 meter walk4 times (9-0 weeks) before treatment, 3 times (6-12 weeks) after treatment

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026